- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library
 |
 |
pepsinogen I? (PG I) antibody and antigen (Recombinant protein)
Diagnostic pepsinogen I? (PG I) antibodies (anti-pepsinogen I, anti-PG I) and antigens (recombinant pepsinogen I? (PG I) protein) for Gastric disease PG I detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to
Neurodegenerative diseases diagnostics
products collection
>>
Product information
| Catalog No. | Description | US $ Price (per mg) |
|---|---|---|
| GMP-h-PG-I-Ag01 | Recombinant human PGA3/PG I Protein | 3090 |
| GMP-h-PG-I-Ab01 | Anti-human PGA3/PG I mouse monoclonal antibody (mAb) | 1953 |
| GMP-h-PG-I-Ab02 | Anti-human PGA3/PG I mouse monoclonal antibody (mAb) | 1953 |
| GMP-h-PG-I-Ab03 | Anti-human PGA3/PG I human monoclonal antibody (mAb) | 1953 |
| GMP-h-PG-I-Ab04 | Anti-human PGA3/PG I human monoclonal antibody (mAb) | 1953 |
Size： 1mg | 10mg | 100mg
Product Description
| Cat No. of Products | GMP-h-PG-I-Ag01 |
| Product Name | Recombinant human PGA3/PG I Protein |
| Target/Biomarker | pepsinogen I(PG I) |
| Expression platform | mammalian |
| Isotypes | Recombinant Antigen |
| Bioactivity validation | pepsinogen I (PG I) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PG I level test of Gastric disease (atrophic gastritis, pernicious anemia, intestinal metaplasia, dysplasia, gastric polyps, and gastric cancer) and related syndrome evaluation. |
| Products description | Recombinant human PGA3/PG I Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-h-PG-I-Ab01, GMP-h-PG-I-Ab02 |
| Product Name | Anti-human PGA3/PG I mouse monoclonal antibody (mAb) |
| Target/Biomarker | pepsinogen I(PG I) |
| Expression platform | CHO |
| Isotypes | Mouse IgG |
| Bioactivity validation | Human pepsinogen I (PG I) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other pepsinogen I (PG I) antibodies in PG I level test of Gastric disease (atrophic gastritis, pernicious anemia, intestinal metaplasia, dysplasia, gastric polyps, and gastric cancer) and related syndrome evaluation. |
| Tag | mFc |
| Products description | Anti-human PGA3/PG I mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-h-PG-I-Ab03, GMP-h-PG-I-Ab04 |
| Product Name | Anti-human PGA3/PG I human monoclonal antibody (mAb) |
| Target/Biomarker | pepsinogen I(PG I) |
| Expression platform | CHO |
| Isotypes | Human lgG1 |
| Bioactivity validation | Human pepsinogen I (PG I) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other pepsinogen I (PG I) antibodies in PG I level test of Gastric disease (atrophic gastritis, pernicious anemia, intestinal metaplasia, dysplasia, gastric polyps, and gastric cancer) and related syndrome evaluation. |
| Tag | hFc |
| Products description | Anti-human PGA3/PG I human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
There are two main types of pepsinogen (PG), namely PG I (PG A) and PG II (PG C). Both of these types are produced in the essential cells in the stomach corpus and fundus and in mucous cervical cells. Unlike PG A, PG C is also produced in the Brunner glands in the proximal duodenum and in the pyloric glands in the antrum [8]. Serum pepsinogen levels reflect the morphological and functional status of the stomach mucosa, so they serve as markers of chronic atrophic gastritis [9]. Low levels of serum PG A and PG A / PG C are observed in patients with atrophic gastritis, pernicious anemia, intestinal metaplasia, dysplasia, gastric polyps, and gastric cancer [8]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261308/
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Facebook
LinkedIn
Twitter
Comments